TY - BOOK AU - Kallunki,Tuula TI - Killing cancer: : discovery and selection of new target molecules SN - 9783039434411 PY - 2020///] CY - Basel, Switzerland PB - MDPI KW - Cancer KW - Treatment KW - Electronic books N1 - Includes bibliographical references; Seeking and exploring efficient ways to target cancer; Immunotherapy, inflammation and colorectal cancer; Oncofetal chondroitin sulfate : a putative therapeutic target in adult and pediatric solid tumors; Targeting mTOR and metabolism in cancer : lessons and innovations; Mutations that confer drug-resistance, oncogenicity and intrinsic activity on the ERK MAP kinases - current state of the art; The pyrazolo[3,4-d]pyrimidine derivative, SCO-201, reverses multidrug resistance mediated by ABCG2/BCRP; The vacuolar H+ ATPase α3 subunit negatively regulates migration and invasion of human pancreatic ductal adenocarcinoma cells; Ferlin overview : from membrane to cancer biology; Zinc finger transcription factor MZF1 - a specific regulator of cancer invasion; Targeting the NPL4 adaptor of p97/VCP segregase by disulfiram as an emerging cancer vulnerability evokes replication stress and DNA damage while silencing the ATR pathway; Disruption of the NF-κB/IL-8 signaling axis by sulconazole inhibits human breast cancer stem cell formation; Dexamethasone inhibits spheroid formation of thyroid cancer cells exposed to simulated microgravity; The oncogene AF1Q is associated with WNT and STAT signaling and offers a novel independent prognostic marker in patients with resectable esophageal cancer; Comment on “dexamethasone inhibits spheroid formation of thyroid cancer cells exposed to simulated microgravity”; Science between bioreactors and space research - response to comments by Joseph J. Bevelacqua et al. on “dexamethasone inhibits spheroid formation of thyroid cancer cells exposed to simulated microgravity” UR - https://www.mdpi.com/books/pdfdownload/book/3081 ER -